IDXXCongressional Stock Trades
Idexx Laboratories Inc
In Vitro & In Vivo Diagnostic Substances
Congressional stock trades in Idexx Laboratories Inc (IDXX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
21
Politicians Trading
5
Last Traded
Aug 3, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Byron DonaldsR | Oct 7, 2025 | Sep 4, 2025 | Buy | $1,001 - $15,000 | -20.11% |
| Byron DonaldsR | Oct 7, 2025 | Sep 4, 2025 | Buy | $1,001 - $15,000 | -20.11% |
| Robert BresnahanR | Jun 9, 2025 | May 15, 2025 | Buy | $1,001 - $15,000 | -0.07% |
| Jefferson ShreveR | May 8, 2025 | Apr 7, 2025 | Buy | $50,001 - $100,000 | +35.00% |
| Jefferson ShreveR | Apr 11, 2025 | Mar 13, 2025 | Buy | $15,001 - $50,000 | +25.93% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Buy | $1,001 - $15,000 | +11.26% |
Price History
About Idexx Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.